*This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other
governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid,
TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance
Plan, or any other federal or state health care programs. Please see the co-pay card for full terms and conditions.
References: 1. Coleman CC, King BR, Bolden-Watson C, et al. A placebo-controlled comparison of the effects on sexual functioning of
bupropion sustained release and fluoxetine. Clin Ther. 2001;23:1040-1058. 2. Coleman CC, Cunningham LA, Foster VJ, et al. Sexual
dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry. 1999;11:205-215. 3. Croft H, Settle E Jr., Houser T, et al. A placebo-controlled comparison
of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther.
1999;21:643-658. 4. Clayton AH, Croft HA, Horrigan JP, et al. Bupropion extended release compared with escitalopram: effects on
sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry.
2006;67:736-746. 5. Data on file, GlaxoSmithKline (WELL AK1A4006). 6. Wellbutrin XL (bupropion hydrochloride) Prescribing Information. 2014. Valeant Pharmaceuticals, Inc.
Wellbutrin XL is a registered trademark of GlaxoSmithKline LLC used under license. All other product/brand names are trademarks of
their respective owners.
© 2016 Valeant Pharmaceuticals North America LLC